“In the end, it was clear that the evidence supporting the efficacy of Brain Balance was weak, and that company marketing strategies targeted vulnerable parents searching for any treatment (however costly and non-proven) that might help their children.
Additionally, we were able to clarify for the public that childhood disorders such as ADHD, dyslexia, and autism are indeed different conditions, and that while there may be some overlapping symptoms, the treatments for each are often very different, and should be targeted at the individual child.”–Mark Mahone, Ph.D., ABPP

https://www.npr.org/sections/health-shots/2018/06/18/616805015/cutting-edge-program-for-children-with-autism-and-adhd-rests-on-razor-thin-evide?fbclid=IwAR2UqV7eeYtvLP4xOiqrqYoQX39CRmPq8VjzHLe9DKw1nLRtj-Vm1pNS6aU